Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis
Clinical trial NCT06565273 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06565273
- Sponsor
- SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-24
- Primary completion
- 2026-06-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.